I haven't looked at it closely but I thought MSB was targeting a novel type of anti-inflammatory for arthritis and possibly airways diseases .
my understanding is pain type meds can be incredibly hard to get across the line as they aren't live saving, they simply improve quality of life. You certainly don't see a lot of new ones. The "new" pain type meds seem almost exclusively alternative uses of other drugs. Most notable in recent times Lyrica/pregablin appeared to be a repackaged epilepsy drug that was used off label for pain and got a heap of traction with some clever pharmacy reps and a tonne of marketing (so it seemed in Aus).
from what I can tell oncology drugs need to be safe first, then effective. Presumably as the logic would be to offer it to patients who've tried other treatments and are potentially terminal.
obviously it is still critical to get study design right though
- Forums
- ASX - By Stock
- RAC
- Pillar 2 - Breast Cancer
Pillar 2 - Breast Cancer, page-98
-
-
- There are more pages in this discussion • 32 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAC (ASX) to my watchlist
|
|||||
Last
$1.56 |
Change
0.010(0.65%) |
Mkt cap ! $265.8M |
Open | High | Low | Value | Volume |
$1.55 | $1.56 | $1.51 | $95.69K | 62.25K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 3015 | $1.55 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.56 | 4018 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 3015 | 1.550 |
2 | 17973 | 1.530 |
1 | 19190 | 1.525 |
1 | 20000 | 1.520 |
1 | 500 | 1.500 |
Price($) | Vol. | No. |
---|---|---|
1.560 | 4018 | 1 |
1.570 | 4602 | 2 |
1.580 | 15715 | 3 |
1.600 | 2319 | 1 |
1.645 | 10000 | 1 |
Last trade - 16.10pm 23/08/2024 (20 minute delay) ? |
Featured News
RAC (ASX) Chart |
The Watchlist
SER
STRATEGIC ENERGY RESOURCES LIMITED
David DeTata, Managing Director
David DeTata
Managing Director
SPONSORED BY The Market Online